| P50 | author | Zhiguo Chen | Q59694220 |
| P2093 | author name string | Xiaobo Li | |
| | Jiayin Wang | |
| | Chunlin Zou | |
| | Shuyan Wang | |
| | Yunqian Guan | |
| | Y Alex Zhang | |
| | Zhenhua Ren | |
| P2860 | cites work | Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro | Q85026343 |
| | The effects of a selective dopamine D2 receptor agonist on behavioral and pathological outcome in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated squirrel monkeys | Q46568198 |
| | Growth, differentiation, and biochemical signatures of rhesus monkey mesenchymal stem cells | Q46671287 |
| | Lentiviral gene transduction of mouse and human stem cells | Q47814714 |
| | A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey | Q48635335 |
| | Effect of pre-ischaemic conditioning on hypoxic depolarization of dopamine efflux in the rat caudate brain slice measured in real-time with fast cyclic voltammetry. | Q49043394 |
| | Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. | Q51214960 |
| | Motor slowing and parkinsonian signs in aging rhesus monkeys mirror human aging. | Q52164243 |
| | An automated movement assessment panel for upper limb motor functions in rhesus monkeys and humans. | Q52174444 |
| | Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group | Q57273925 |
| | Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization | Q69802862 |
| | Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation | Q80816659 |
| | Spontaneous transformation of cynomolgus mesenchymal stem cells in vitro: further confirmation by short tandem repeat analysis | Q83153283 |
| | Functional recovery in parkinsonian monkeys treated with GDNF | Q24312738 |
| | MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts | Q27313884 |
| | Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease | Q28187904 |
| | Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor | Q28237467 |
| | Ancient co-speciation of simian foamy viruses and primates | Q28240174 |
| | Crossroads in GDNF therapy for Parkinson's disease | Q28296616 |
| | Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo | Q28306009 |
| | Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism | Q28328337 |
| | Parkinson's disease: mechanisms and models | Q29547424 |
| | Transplantation of embryonic dopamine neurons for severe Parkinson's disease | Q29617304 |
| | The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease | Q33656315 |
| | Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult | Q33964044 |
| | Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease | Q34035718 |
| | Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease | Q34427198 |
| | Immunomodulatory effects of fetal and adult mesenchymal stem cells | Q35601901 |
| | Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys. | Q35914466 |
| | SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings | Q37118064 |
| | Cellular repair of CNS disorders: an immunological perspective. | Q37218561 |
| | Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 |
| | Human mesenchymal stem cells efficiently manage oxidative stress | Q39716782 |
| | Derivation, characterization and gene modification of cynomolgus monkey mesenchymal stem cells | Q39875298 |
| | Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease | Q39903811 |
| | Role of transmitter uptake mechanisms in synaptic neurotransmission | Q39906302 |
| | GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys | Q39975890 |
| | The sensitivity of human mesenchymal stem cells to ionizing radiation | Q40256057 |
| | Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease | Q40326219 |
| | Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates | Q40339968 |
| | Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. | Q40464992 |
| | Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. | Q40466228 |
| | Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. | Q40678042 |
| | Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys | Q40695369 |
| | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 |
| | Dopaminergic neurons protected from degeneration by GDNF gene therapy | Q41128316 |
| | GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis | Q41221025 |
| | Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. | Q43234179 |
| | 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET. | Q44261629 |
| | A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease | Q44571920 |
| | Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model | Q45178238 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| P304 | page(s) | 2786 | |
| P577 | publication date | 2013-09-27 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys | |
| P478 | volume | 3 | |